Obermatt
See Similar Stocks →

Flags

Earnings warning

Brainsway

TLV:BWAY · IL0011007189
Health Care Equipment & SuppliesSmall

360

70
EV / EBIT5
Price / Owner Earnings11
Owner Earnings Yield72
Dividend Yield1
Price/Sales5
EV / Gross Profit19
Price/Book9
Return on Capital75
Cash Return on Capital84
Return on Equity87
EBIT Margin80
Gross Profitability52
Cash Conversion56
Accruals11
Owner Earnings Margin88
Sales growth100
Profit Growth13
Long-Term EPS Growth56
Owner Earnings Growth88
Reinvestment18
Price momentum97
Debt load93
Refinancing14
Debt Payback100
Liquidity32
Analyst ratings100
Expectations trend50
Market mood95
Value Creation18/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Brainsway generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryIsrael
IndustryHealth Care Equipment & Supplies
SizeSmall
TypePublic Company
ExchangeTASE
Founded2006
Employees129
Websitebrainsway.com
ISINIL0011007189
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Pain ManagementAddictionHealth DiagnosticsNeurologyPsychiatryNeuroscienceCentral Nervous SystemBiotechnologyHealth CareLife Science

Description

BrainsWay Ltd. (BrainsWay) is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platfo…

Analysis

Hope premium

BrainsWay Ltd. carries what we call a hope premium: an average business trading at an ambitious price.

The price is expensive. You pay 75.4× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone.

The trajectory is solid and the balance sheet is sturdy. The company scores 18/20 on our value-creation score: strong value creator. Analyst sentiment is cautious.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
44
2023202420252026

All-time high

92

Jan 2024

All-time low

37

Mar 2026

Average rank

63

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
5
11
26
37
Price/Earnings
1
1
8
8
Price/Book
9
15
32
74
Dividend Yield
1
1
1
1
Value (overall)
1
4
21
51

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Brainsway with its peers
InMode
NSQ:INMD
86
CountryIsrael
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Embla Medical
CPH:EMBLA
61
CountryIceland
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Guerbet
PAR:GBT
4
CountryFrance
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
EDAP TMS
NMQ:EDAP
11
CountryFrance
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Medtronic
NYQ:MDT
70
CountryIreland
IndustryHealth Care Equipment & Supplies
SizeXX-Large
Full Stock Analysis →
Ambu
CPH:AMBU B
77
CountryDenmark
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →